In particular, Lee et al. (23) found that YAP1 was overexpressed in the nucleus and cytoplasm of papillary thyroid carcinoma and anaplastic thyroid cancer, with a higher frequency in patients carrying a V600E BRAF mutation. Here, YAP1 is linked to differentiated thyroid carcinoma.